TPM1
Tropomyosin alpha-1 chain
Also known as: C15orf13, CMH3, TPM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09493
- Gene
- TPM1
- Ensembl
- ENSG00000140416
- Chromosome
- 15
- Canonical length
- 284 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Actin filaments,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]
Canonical amino-acid sequenceUniProt
284 residues, UniProt reviewed canonical sequence.
>P09493|TPM1
1 MDAIKKKMQM LKLDKENALD RAEQAEADKK AAEDRSKQLE DELVSLQKKL KGTEDELDKY
61 SEALKDAQEK LELAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA
121 DESERGMKVI ESRAQKDEEK MEIQEIQLKE AKHIAEDADR KYEEVARKLV IIESDLERAE
181 ERAELSEGKC AELEEELKTV TNNLKSLEAQ AEKYSQKEDR YEEEIKVLSD KLKEAETRAE
241 FAERSVTKLE KSIDDLEDEL YAQKLKYKAI SEELDHALND MTSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TPM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 11,881 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 11,881 nTPM
- heart muscle: 10,511 nTPM
- tongue: 4,840 nTPM
- colon: 2,621 nTPM
- blood vessel: 1,843 nTPM
- smooth muscle: 1,638 nTPM
Single-cell type
- smooth muscle cells: 5,778 nCPM
- extravillous trophoblasts: 4,741 nCPM
- breast myoepithelial cells: 3,061 nCPM
- hepatic stellate cells: 2,634 nCPM
- vascular smooth muscle cells: 2,223 nCPM
- thymic myoid cells: 2,042 nCPM
Immune cell
- basophil: 49 nTPM
- intermediate monocyte: 19 nTPM
- total PBMC: 16 nTPM
- non-classical monocyte: 14 nTPM
- myeloid DC: 14 nTPM
- neutrophil: 11 nTPM
Brain region
- choroid plexus: 90 nTPM
- cerebral cortex: 76 nTPM
- hippocampal formation: 76 nTPM
- basal ganglia: 76 nTPM
- cerebellum: 73 nTPM
- thalamus: 70 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TPM1.
Disease | AllUniProt
Conditions TPM1 is implicated in, by any mechanism.
- Cardiomyopathy, familial hypertrophic, 3 (CMH3) MIM:115196
- Cardiomyopathy, dilated, 1Y (CMD1Y) MIM:611878
- Left ventricular non-compaction 9 (LVNC9) MIM:611878
Disease | GeneticClinVar
54 pathogenic / likely-pathogenic of 1,072 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypertrophic cardiomyopathy
- Dilated cardiomyopathy 1Y
- Hypertrophic cardiomyopathy 3
- Primary dilated cardiomyopathy
- Cardiovascular phenotype
ReferencesPubMed · IEDB
Publications for TPM1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease.
2020 · Front Pharmacol · RCR 0.8 · 14 citations - Autoantibody reactome analysis reveals novel biomarkers for idiopathic retroperitoneal fibrosis.
2026 · Rheumatology (Oxford)
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.87
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- cardiac muscle contraction
- cellular response to reactive oxygen species
- cytoskeleton organization
- muscle filament sliding
- negative regulation of cell migration
- negative regulation of vascular associated smooth muscle cell migration
- negative regulation of vascular associated smooth muscle cell proliferation
- positive regulation of cell adhesion
- positive regulation of stress fiber assembly
- regulation of cell shape
- regulation of heart contraction
- regulation of muscle contraction
- ruffle organization
- sarcomere organization
- ventricular cardiac muscle tissue morphogenesis
- wound healing
- positive regulation of heart rate by epinephrine
Molecular functions
- actin binding
- actin filament binding
- cytoskeletal protein binding
- identical protein binding
- protein heterodimerization activity
- protein homodimerization activity
- structural constituent of cytoskeleton
- structural constituent of muscle
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TPM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TPM1 as an antibody target. Whether an autoantibody or antibody against TPM1 could matter depends on whether native TPM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TPM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TPM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...